The authors recommend a strategy for classifying similar nonstainless-steel surfaces into three groups based upon the analytical recovery that was observed in this study.
Jeffrey D. Hofer
Advertisement
Jeffrey D. Hofer is a senior statistician in Global Statistical Sciences at Eli Lilly and Company.
Articles by Jeffrey D. Hofer
This article discusses a straightforward approach that scientists may use to descide how many nonsuspect restest results are required to provide sufficient evidence to overcome an initial suspect result.
Advertisement
Latest Updated Articles
- Routine Sample Size for a Retest Procedure
November 2nd 2003
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why the First Generic Single-Dose Flu Antiviral Approval Matters
4
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
5